Patent · US Active

Hepatitis C virus inhibitors

US9499550B2 · kind B2 · utility

0Cited by

16References

18Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Li-Qiang Sun · Foster City, US
Eric Mull · Guilford, US
Eric P. Gillis · Cheshire, US
Michael S. Bowsher · Prospect, US
Qian Zhao · Louisville, US
Kishore V. Renduchintala · Hyderabad, IN
Kandhasamy Sarkunam · Hosur, IN
Pulicharla Nagalakshmi · Bengaluru, IN
P.V.K. Suresh Babu · Bengaluru, IN
Paul Michael Scola · Glastonbury, US

Key dates

Filing date	Oct 19, 2012
Grant date	Nov 22, 2016
Priority date	—
Expiry date	Oct 19, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/05
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.